Abstract
SUMMARY
Clinical guidelines recommend avoiding the use of medications to manage personality disorder. In clinical practice, however, substantial amounts of medication are used. In this article, we summarise the recommendations of guidelines published in various countries in the past 15 years. We review the evidence from randomised controlled trials and recent reviews, discuss the discordance between guidance and clinical practice and give recommendations on what a clinician should consider if they choose to prescribe in cases of severe disturbances in mood or behaviour despite the lack of evidence.
Publisher
Royal College of Psychiatrists
Reference33 articles.
1. National Institute for Health and Care Excellence (2009b) Antisocial Personality Disorder: Prevention and Management (Clinical Guideline CG77). NICE.
2. Lamotrigine for people with borderline personality disorder: a RCT
3. A systematic review of the role of clozapine for severe borderline personality disorder
4. National Institute for Health and Care Excellence (2015) Personality Disorders: Borderline and Antisocial (Quality Standard QS88). NICE.
5. Antipsychotics for aggression in adults: A meta-analysis